Autori: Cutrona C

Filtra

Data

Can the CHOP-INTEND be used as An Outcome Measure in the First Months of Age? Implications for Clinical Trials and Real World Data

Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?

Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment?

Early treatment of type II SMA slows rate of progression of scoliosis

Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0

A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?

Long term follow-up of scoliosis progression in type II SMA patients

Assessing floppy infants: a new module

Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Torna in alto